The study found that West African genetic ancestry was associated with shorter disease-free survival, particularly for women with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.

Under the old system, genetic counselors would complete paper requisitions, and results would return as PDFs that had to be manually uploaded into patients' electronic health records.

Kim and colleagues will study whether this protein hinders the ability of the immune system to fight MDS and whether it can be blocked to treat MDS.

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

The project seeks to reduce the time for clinical chart abstraction by 90% while maintaining human-level accuracy.

Launched Sept. 17-19 during the World Cancer Congress in Geneva, Switzerland, “Rewriting Cancer” aims to enhance understanding and inspire audiences by exploring the most innovative, inclusive and impactful solutions for cancer prevention, diagnosis, treatment and care globally.